a clear trendP =0.010
However, aspirin in any dosage and up to 7 days before the biopsy showed a clear trend toward more major complications ( e.g. , OR of 4.39, P =0.010 for aspirin in any dosage within 7 days of the biopsy).
However, aspirin in any dosage and up to 7 days before the biopsy showed a clear trend toward more major complications ( e.g. , OR of 4.39, P =0.010 for aspirin in any dosage within 7 days of the biopsy).
15 reported no significant association between aspirin use and major bleeding complications in native kidney biopsies, despite an apparent trend in the latter study toward more complications under antiplatelet agent exposure that could arguably become significant with a greater sample size.